TREK-1 related research peptide
Spadin analog research peptide
A short research peptide associated with TREK-1 / spadin pathway work in depression and neurophysiology models.
- Evidence:
- Preclinical evidence primarily
- Status:
- Research-stage
- Reviewed:
- 2026-08-03
Also known as: Spadin analog research peptide
What is Spadin analog research peptide?
A short research peptide associated with TREK-1 / spadin pathway work in depression and neurophysiology models.
This profile is educational. It organizes publicly discussed research context for Spadin analog research peptide and related naming aliases — it is not a treatment guide.
Proposed mechanism
Proposed modulation of TREK-1 potassium channel signaling pathways studied in preclinical mood/neuro research.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Preclinical evidence primarily
Preclinical evidence grade: Early-stage human research
PE-22-28 is discussed in experimental neuropeptide contexts. Human clinical evidence is minimal.
Key uncertainties
- Clinical translation
Research areas being studied
- Neurophysiology
- Mood research models
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Not characterized in humans
Additional risks & considerations
- Unknown human safety
Regulatory status
Research-stage
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Spadin analog research peptide?
A short research peptide associated with TREK-1 / spadin pathway work in depression and neurophysiology models.
How does Spadin analog research peptide work (proposed mechanism)?
Proposed modulation of TREK-1 potassium channel signaling pathways studied in preclinical mood/neuro research.
What is Spadin analog research peptide being researched for?
Spadin analog research peptide has been discussed in research contexts including: Neurophysiology, Mood research models.
What does current evidence say about Spadin analog research peptide?
Preclinical evidence primarily. PE-22-28 is discussed in experimental neuropeptide contexts. Human clinical evidence is minimal.
What safety considerations are noted for Spadin analog research peptide?
Reported or discussed considerations include: Not characterized in humans; Unknown human safety. This is educational information, not medical advice.
References & sources
- Mazella J et al. (2010). Spadin and TREK-1 in depression models — Nat Neurosci. Evidence type: animal.
Prefer interactive tools? Open the PepGuide library entry for Spadin analog research peptide or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.